Cargando…

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

PURPOSE: This study aimed to evaluate Atorvastatin (ATO)-associated hepatotoxicity using prescription sequence symmetry analysis (PSSA), based on a health insurance database of a Chinese population living in Jiangsu Province, China. METHODS: Patients prescribed ATO and hepatoprotective drugs in 2017...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Haiping, Wu, Jiani, Zhang, Zhuolin, Qian, Haisheng, Wang, Yifan, Yang, Miaomiao, Cheng, Yinchu, Tang, Shaowen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602299/ https://www.ncbi.nlm.nih.gov/pubmed/31417267 http://dx.doi.org/10.2147/TCRM.S204860

Ejemplares similares

Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients
por: Kalantari, Saeed, et al.
Publicado: (2014)

Recurrence and Severe Worsening of Hepatotoxicity After Reintroduction of Atorvastatin in Combination With Ezetimibe
por: Bergland Ellingsen, Silje, et al.
Publicado: (2017)

Atorvastatin attenuates ethanol-induced hepatotoxicity via antioxidant and anti-inflammatory mechanisms
por: Zamani, Ehsan, et al.
Publicado: (2017)

NR1I2 genetic polymorphisms and the risk of anti‐tuberculosis drug‐induced hepatotoxicity: A systematic review and meta‐analysis
por: Yang, Miaomiao, et al.
Publicado: (2020)

High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort
por: Clarke, Alan T., et al.
Publicado: (2016)

Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis
por: Li, Xiao-xiao, et al.
Publicado: (2021)

Detecting Potential Adverse Reactions of Sulpiride in Schizophrenic Patients by Prescription Sequence Symmetry Analysis
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2014)

Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model
por: Hamzeh, Maedeh, et al.
Publicado: (2018)

Atorvastatin Induces Hepatotoxicity in Diabetic Rats via Oxidative Stress, Inflammation, and Anti-Apoptotic Pathway
por: Zeng, Hanqing, et al.
Publicado: (2019)

Prescription rate of medications potentially contributing to lower urinary tract symptoms and detection of adverse reactions by prescription sequence symmetry analysis
por: Hashimoto, Masako, et al.
Publicado: (2015)

The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1
por: Shu, Nan, et al.
Publicado: (2016)

Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries
por: Pratt, Nicole, et al.
Publicado: (2015)

A Multiview Model for Detecting the Inappropriate Use of Prescription Medication: Machine Learning Approach
por: Zhuo, Lin, et al.
Publicado: (2020)

Myopathy in Patients Taking Atorvastatin: A Pilot Study
por: Manoj, K., et al.
Publicado: (2017)

Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis
por: Pouwels, Koen B., et al.
Publicado: (2016)

Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products
por: Patel, Dhavalkumar N., et al.
Publicado: (2015)

Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: A systematic review
por: Idema, Demy L., et al.
Publicado: (2018)

The impact of hypotestosteronemia on cardiometabolic effects of atorvastatin in men with hypercholesterolemia: a pilot study
por: Krysiak, Robert, et al.
Publicado: (2021)

Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke
por: Min, Lianqiu, et al.
Publicado: (2013)

Lycium Barbarum Polysaccharides and Wolfberry Juice Prevent DEHP-Induced Hepatotoxicity via PXR-Regulated Detoxification Pathway
por: Liu, Huan, et al.
Publicado: (2021)

Hepatotoxicity Induced by Sophora flavescens and Hepatic Accumulation of Kurarinone, a Major Hepatotoxic Constituent of Sophora flavescens in Rats
por: Jiang, Peng, et al.
Publicado: (2017)

Atorvastatin-induced pancreatitis
por: Prajapati, Samir, et al.
Publicado: (2010)

Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019)

Analysis of Drug-Resistance Characteristics and Genetic Diversity of Multidrug-Resistant Tuberculosis Based on Whole-Genome Sequencing on the Hainan Island, China
por: Wang, Jieying, et al.
Publicado: (2023)

RNA-Sequencing Analysis of HepG2 Cells Treated with Atorvastatin
por: Stormo, Camilla, et al.
Publicado: (2014)

Evaluation of the Persistence of Higher-Order Strand Symmetry in Genomic Sequences by Novel Word Symmetry Distance Analysis
por: Huang, Bi, et al.
Publicado: (2019)

Additive effects of atorvastatin combined with sitagliptin on rats with myocardial infarction: a pilot study
por: Ke, Xiao, et al.
Publicado: (2017)

Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study
por: Krysiak, Robert, et al.
Publicado: (2022)

Effect of atorvastatin 1% mouthwash in the prevention of radiotherapy induced mucositis: A pilot study
por: Ala, Shahram, et al.
Publicado: (2022)

15-Lipoxygenase-1 Is Involved in the Effects of Atorvastatin on Endothelial Dysfunction
por: Zhang, Peng, et al.
Publicado: (2016)

An early neuroprotective effect of atorvastatin against subarachnoid hemorrhage
por: Chen, Jun-Hui, et al.
Publicado: (2020)

Acute atorvastatin treatment restores the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats
por: Sun, Tao, et al.
Publicado: (2017)

HEPATOTOXICITY OF EUGENOL
por: Soundran, Vijaya, et al.
Publicado: (1994)

Comparing the combination therapy of ezetimibe and atorvastatin with atorvastatin monotherapy for regulating blood lipids: a systematic review and meta-analyse
por: Ai, Cong, et al.
Publicado: (2018)

Atorvastatin and cardiovascular risk in the elderly – patient considerations
por: Acharjee, Subroto, et al.
Publicado: (2008)

Efficacy and Safety of Atorvastatin in South Asian Patients with Dyslipidemia: An Open Label Noncomparative Pilot Study
por: Patel, Jeetesh V, et al.
Publicado: (2005)

Atorvastatin-induced acute pancreatitis
por: Deshpande, Prasanna R., et al.
Publicado: (2011)

Bioenhancing effects of naringin on atorvastatin
por: Sama, Venkatesh, et al.
Publicado: (2019)

Atorvastatin-Induced Refractory Thrombocytopenia
por: Ghuman, Jasmine, et al.
Publicado: (2021)

Incidence and risk of regorafenib-induced hepatotoxicity
por: Zhao, Bin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9lr5uhugkban8p7rn5cer4i54u